Development and Validation of Two Screening Assays for the Hepatitis C Virus NS3 Q80K Polymorphism Associated with Reduced Response to Combination Treatment Regimens Containing Simeprevir.
J Clin Microbiol
; 53(9): 2942-50, 2015 Sep.
Article
in En
| MEDLINE
| ID: mdl-26135875
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Mass Screening
/
Viral Nonstructural Proteins
/
Hepatitis C, Chronic
/
Mutation, Missense
/
Genotyping Techniques
/
Simeprevir
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
J Clin Microbiol
Year:
2015
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Estados Unidos